Myriad Genetics Inc (NASDAQ:MYGN)
| 25.61 Delayed Data As of Dec 06 |  -0.06 / -0.23%Today’s Change | 20.10 Today|||52-Week Range 48.40 | -11.90% Year-to-Date |
Latest MYGN News | Press Releases
No recent news for Myriad Genetics Inc.
Today’s Trading
| Previous close | 25.67 |
| Today’s open | 25.94 |
| Day’s range | 25.32 - 26.24 |
| Volume | 497,802 |
| Average volume (3 months) | 1,358,569 |
| Market cap | $1.9B |
Data as of 4:00pm ET, 12/06/2019
Growth & Valuation
| Earnings growth (last year) | -96.69% |
| Earnings growth (this year) | -37.80% |
| Earnings growth (next 5 years) | +14.70% |
| Revenue growth (last year) | +10.16% |
| P/E ratio | NM |
| Price/Sales | 2.48 |
| Price/Book | 1.74 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VCYTVeracyte Inc | -0.81 | -2.70% |
| --Quidel Corp | 0.00 | 0.00% |
| CDNACareDx Inc | +0.34 | +1.63% |
| AXDXAccelerate Diagnosti... | +0.36 | +2.32% |
Data as of 4:00pm ET, 12/06/2019
Financials
| Next reporting date | February 11, 2020 |
| EPS forecast (this quarter) | $0.31 |
| Annual revenue (last year) | $851.1M |
| Annual profit (last year) | $4.6M |
| Net profit margin | 0.54% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Salt Lake City, Utah |
Forecasts
